October 6–8, 2023

BOSTON

Renaissance Boston Waterfront

Join Mailing List

Where passion
& purpose connect

The 2023 Clinical Pathways Congress is debuting a new partnership with the Cancer Care Business Exchange.

Join us as we reimagine how the industry delivers and pays for cancer care.

This new collaboration expands the conversation to the stakeholders who have interest, influence, and impact on the evolving business models of cancer care, and how innovation will continue to improve them.

Register Now

Building better
pathways starts here

Over the three-day agenda, you’ll explore the latest clinical updates impacting patient outcomes, gain best practices for successfully putting patients at the center of care, plus have the opportunity to gain fresh perspectives on how to ensure you are providing the right drug, at the right price, to the right patient.

Explore the conference newsroom to read coverage from last year’s event to see how we are taking discussion and putting it into action.

View 2022 Highlights

Help us reimagine
cancer care

The Congress brings together the biggest names across the cancer care spectrum and provides a unique opportunity for meaningful engagement with payer and provider-facing pathway architects. If you are interested in being a part of this year’s event, we encourage you to reach out to learn more about our partnership opportunities. Together we can unlock the potential of cancer care to deliver a brighter future for patients.

Get in Touch

Meet the Conference Leaders

Robin T. Zon

MD, FACP, FASCO

Michiana Hematology-Oncology, PC
Mishawaka, IN

Barry Russo

MBA

The Center for Cancer and Blood Disorders
Fort Worth, TX

Andrew Hertler

MD, FACP

New Century Health
Brea, CA

Deirdre Saulet

PhD

Carrum Health
Richmond, VA

Frederick M. Schnell

MD, FACP

National Cancer Treatment
Alliance/Community Oncology Alliance
Washington, DC

Erich Mounce

MSHA

Oncology Care Partners
La Grange, TN

Ronald Barkley

MS, JD

Cancer Center Business Development Group
Vero Beach, FL

Alan Balch

PHD

National Patient Advocate Foundation
Hampton, VA

Carla Balch

MS

Spesana
St. Louis, MO

Alexis Bortniker

JD

Foley & Lardner LLP
San Diego, CA

Nina Chavez

MBA

Flatiron Health
Albuquerque, NM

Stephen B. Edge

MD, FACS, FASCO

Jacobs School of Medicine, University at Buffalo
Buffalo, NY

James Hamrick

MD, MPH

Flatiron Health
Atlanta, GA

John E. Hennessy

MBA

Valuate Health Consultancy
Overland Park, KS

Manasi Kapoor

MBA

Memorial Sloan Kettering
Washington, DC

Ira Klein

MD

Tempus Labs
New York, NY

Wui-Jin Koh

MD

National Comprehensive Cancer Network
Ft. Washington, PA

Michael Kolodziej

MD

ADVI
Washington, DC

Harlan Levine

MD

City of Hope
Los Angeles, CA

Barbara McAneny

MD

New Mexico Oncology Hematology Consultants, Ltd
Albuquerque, NM

Mahek A. Shah

MD, MBA, MS

Harvard Business School
Boston, MA

Ed Rodgers

ClinicalPath/Elsevier
Pittsburgh, PA

Adria Warren

JD

Foley & Lardner LLM
Boston, MA

Who
should attend

  • Cancer Center Directors
  • Oncology Practice Managers
  • Oncologists & Hematologists
  • Pathway Development Executives
  • Commercial & Government Payers
  • Reimbursement Specialists
  • Oncology Pharmacists

The Journal of Clinical Pathways serves as the official media partner for the Congress. The monthly publication is the premiere forum to advance the discussion, development, and implementation of clinical pathways to drive the delivery of high-quality, cost-effective care. Learn more about this valuable resource and continue your pathways education throughout the year.

Subscribe Today